Update
Teva to Sell Californian Plant as Part of Cost-Cutting Initiative
Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs